Literature DB >> 27350740

Successful treatment of ileal ulcers caused by immunosuppressants in two organ transplant recipients.

Yun-Wei Guo1, Hua-Ying Gu1, Kodjo-Kunale Abassa1, Xian-Yi Lin1, Xiu-Qing Wei1.   

Abstract

Although gastroduodenal ulcers are common in solid organ transplant patients, there are few reports on multiple giant ulcers in the distal ileum and ileocecal valve caused by immunosuppressants Herein, we report on a liver transplant recipient and a renal transplant recipient with multiple large ulcers in the distal ileum and ileocecal valve who rapidly achieved ulcer healing upon withdrawal of sirolimus or tacrolimus and administration of thalidomide. In case 1, a 56-year-old man with primary hepatocellular carcinoma had received a liver transplantation. Tacrolimus combined with sirolimus and prednisolone was used as the anti-rejection regimen. Colonoscopy was performed because of severe abdominal pain and diarrhea at post-operative month 10. Multiple giant ulcers were found at the ileocecal valve and distal ileum. The ulcers healed rapidly with withdrawal of sirolimus and treatment with thalidomide. There was no recurrence during 2 years of follow-up. In case 2, a 34-year-old man with end-stage kidney disease received kidney transplantation and was put on tacrolimus combined with mycophenolate mofetil and prednisolone as the anti-rejection regimen. Twelve weeks after the operation, the patient presented with hematochezia and severe anemia. Colonoscopy revealed multiple large ulcers in the ileocecal valve and distal ileum, with massive accumulation of fresh blood. The bleeding ceased after treatment with intravenous somatostatin and oral thalidomide. Tacrolimus was withdrawn at the same time. Colonoscopy at week 4 of follow-up revealed remarkable healing of the ulcers, and there was no recurrence of bleeding during 1 year of follow-up. No lymphoma, tuberculosis, or infection of cytomegalovirus, Epstein-Barr virus, or fungus was found in either patient. In post-transplantation cases with ulcers in the distal ileum and ileocecal valve, sirolimus or tacrolimus should be considered a possible risk factor, and withdrawing them or switching to another immunosuppressant might be effective to treat these ulcers.

Entities:  

Keywords:  Ileal ulcers; Kidney transplantation; Liver transplantation; Sirolimus; Tacrolimus

Mesh:

Substances:

Year:  2016        PMID: 27350740      PMCID: PMC4917622          DOI: 10.3748/wjg.v22.i24.5616

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

Review 1.  Do wound complications or lymphoceles occur more often in solid organ transplant recipients on mTOR inhibitors? A systematic review of randomized controlled trials.

Authors:  Liset H M Pengel; Liang Q Liu; Peter J Morris
Journal:  Transpl Int       Date:  2011-09-29       Impact factor: 3.782

2.  Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.

Authors:  S Bataille; V Moal; J Gaudart; M Indreies; R Purgus; B Dussol; C Zandotti; Y Berland; H Vacher-Coponat
Journal:  Transpl Infect Dis       Date:  2010-12       Impact factor: 2.228

3.  Gastrointestinal complications in renal transplant recipients detected by endoscopic biopsies in a developing country.

Authors:  Muhammed Ishaque; Rahma Rashid; Muhammed Mubarak
Journal:  Indian J Gastroenterol       Date:  2015-03-12

4.  Clinical significance of gastrointestinal bleeding after living donor liver transplantation.

Authors:  Koichi Kimura; Toru Ikegami; Yuki Bekki; Mizuki Ninomiya; Yo-Ichi Yamashita; Tomoharu Yoshizumi; Shohei Yoshiya; Yuji Soejima; Noboru Harada; Ken Shirabe; Yoshihiko Maehara
Journal:  Transpl Int       Date:  2014-05-10       Impact factor: 3.782

5.  High frequency of ulcers, not associated with Helicobacter pylori, in the stomach in the first year after kidney transplantation.

Authors:  Gabor Telkes; Antal Peter; Zsolt Tulassay; Argiris Asderakis
Journal:  Nephrol Dial Transplant       Date:  2010-07-04       Impact factor: 5.992

6.  The effect of thalidomide on ethanol-induced gastric mucosal damage in mice: involvement of inflammatory cytokines and nitric oxide.

Authors:  Keyvan Amirshahrokhi; Ali-Reza Khalili
Journal:  Chem Biol Interact       Date:  2014-12-03       Impact factor: 5.192

7.  Post-transplant lymphoproliferative disorders in liver transplant recipients: a clinicopathological study.

Authors:  Regina Cheuk-lam Lo; See-ching Chan; Kwong-leung Chan; Alan Kwok-shing Chiang; Chung-mau Lo; Irene Oi-lin Ng
Journal:  J Clin Pathol       Date:  2013-02-19       Impact factor: 3.411

Review 8.  Thalidomide in angiodysplasia-related bleeding.

Authors:  J P Boey; U Hahn; S Sagheer; S J McRae
Journal:  Intern Med J       Date:  2015-09       Impact factor: 2.048

9.  A systematic approach to minimizing wound problems for de novo sirolimus-treated kidney transplant recipients.

Authors:  Ho Yee Tiong; Stuart M Flechner; Lingme Zhou; Alvin Wee; Barbara Mastroianni; Kathy Savas; David Goldfarb; Ithaar Derweesh; Charles Modlin
Journal:  Transplantation       Date:  2009-01-27       Impact factor: 4.939

10.  Complications and mortality after adult to adult living donor liver transplantation: A retrospective cohort study.

Authors:  Emad Hamdy Gad; Ayman Alsebaey; Maha Lotfy; Mohamed Eltabbakh; Ahmed Alshawadfy Sherif
Journal:  Ann Med Surg (Lond)       Date:  2015-04-25
View more
  1 in total

1.  β-arrestin 2 attenuates lipopolysaccharide-induced liver injury via inhibition of TLR4/NF-κB signaling pathway-mediated inflammation in mice.

Authors:  Meng-Ping Jiang; Chun Xu; Yun-Wei Guo; Qian-Jiang Luo; Lin Li; Hui-Ling Liu; Jie Jiang; Hui-Xin Chen; Xiu-Qing Wei
Journal:  World J Gastroenterol       Date:  2018-01-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.